Abstract
Background: Depression is common and has a significant impact on quality of life for many people with multiple sclerosis (MS). A preventive management approach via modification of lifestyle risk factors holds potential benefits. We examined the relationship between modifiable lifestyle factors and depression risk and the change in depression over 2.5 years.Methods: Sample recruited using online platforms. 2,224 (88.9%) at baseline and 1,309 (93.4%) at 2.5 years follow up completed the necessary survey data. Depression risk was measured by the Patient Health Questionnaire-2 (PHQ-2) at baseline and Patient Health Questionniare-9 (PHQ-9) at 2.5-years follow-up. Multivariable regression models assessed the relationships between lifestyle factors and depression risk, adjusted for sex, age, fatigue, disability, antidepressant medication use, and baseline depression score, as appropriate.Results: The prevalence of depression risk at 2.5-years follow-up in this cohort was 14.5% using the PHQ-2 and 21.7% using the PHQ-9. Moderate alcohol intake, being a non-smoker, diet quality, no meat or dairy intake, vitamin D supplementation, omega 3 supplement use, regular exercise, and meditation at baseline were associated with lower frequencies of positive depression-screen 2.5 years later. Moderate alcohol intake was associated with greater likelihood of becoming depression-free and a lower likelihood of becoming depressed at 2.5-years follow-up. Meditating at least once a week was associated with a decreased frequency of losing depression risk, against our expectation. After adjusting for potential confounders, smoking, diet, physical activity, and vitamin D and omega-3 supplementation were not associated with a change in risk for depression.Conclusion: In a large prospective cohort study of people with MS and depression, in line with the emerging treatment paradigm of early intervention, these results suggest a role for some lifestyle factors in depression risk. Further studies should endeavor to explore the impact of positive lifestyle change and improving depression in people living with MS.
Highlights
Multiple sclerosis (MS) is an autoimmune, demyelinating, inflammatory disease of the central nervous system
As part of the wider Health Outcomes and Lifestyle In a Sample of people with Multiple Sclerosis (HOLISM) Study, we previously described the results from our baseline crosssectional study of 2,466 participants with MS [20], finding 19.3% screened positive for depression using the Patient Health Questionnaire-2 [21]
The prevalence of depression at 2.5years review differed between the PHQ-2 and Patient Health Questionnaire-9 (PHQ-9), the PHQ-2 estimating a prevalence of 14.5%, while the PHQ-9 estimated a prevalence of 21.7%
Summary
Multiple sclerosis (MS) is an autoimmune, demyelinating, inflammatory disease of the central nervous system. In addition to its negative impacts on overall quality of life, depression is associated with suicide, a significant cause of mortality for people with MS [4]. Suicidal ideation is strongly associated with depression and can be present even if depressive symptoms are mild [6]. Suicidal ideation is associated with both actual and perceived disability, with depression a mediating factor in this relationship. Depression is a modifiable factor, potentially via both prevention and treatment, to reduce the risk of suicide and improve mortality outcomes for people with MS [6]. Depression is common and has a significant impact on quality of life for many people with multiple sclerosis (MS). We examined the relationship between modifiable lifestyle factors and depression risk and the change in depression over 2.5 years
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
